{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:46:24Z","timestamp":1792752384134,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["1R01CA212138-0"],"award-info":[{"award-number":["1R01CA212138-0"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["1R44CA211013-01"],"award-info":[{"award-number":["1R44CA211013-01"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Use of pegulicianine fluorescence-guided surgery (pFGS) for intraoperative residual tumor assessment in breast cancer lumpectomy surgery removed additional tumor and reduced second surgeries. This study assessed breast satisfaction among patients with and without additional margin excision and preference for optimizing cosmesis versus avoiding a second surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Two clinical trials randomized stages 0 to 3 breast cancer patients to pFGS or standard lumpectomy. For pFGS, additional cavity margin specimens were taken at sites of pegulicianine fluorescence after standard lumpectomy. Surveys of BREAST-Q satisfaction were administered in trials 1 and 2, and surveys of cancer worry and patient preference information (PPI) were administered in trial 2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Satisfaction surveys were completed 6 to 12 months postoperatively by 14 % of the trial 1 and 67 % of the trial 2 patients. The mean postoperative breast satisfaction score was 75.8 (\n                      <jats:italic>n<\/jats:italic>\n                      = 99; range, 15\u2013100) for the pegulicianine-assisted arm patients versus 79.0 (\n                      <jats:italic>n<\/jats:italic>\n                      = 19; range, 35\u2013100) for the control subjects (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.53). The mean breast satisfaction score was 73.6 (\n                      <jats:italic>n<\/jats:italic>\n                      = 52; range, 33\u2013100) among the patients with additional pFGS-assisted cavity margins taken versus 78.5 (\n                      <jats:italic>n<\/jats:italic>\n                      = 66; range, 15\u2013100) (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.17) among those with no additional tissue taken. Overall, 70.6 % of the respondents strongly preferred or preferred avoiding a second surgery, 19.6 % had no preference, and only 9.8 % preferred to optimize cosmetic outcomes. No patient strongly preferred to optimize cosmetic outcomes\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>No decrease in breast satisfaction was observed among the breast cancer lumpectomy patients undergoing pFGS intraoperative margin assessment despite additional tissue removal. Most of the patients valued avoiding a second surgery over maximizing cosmetic outcome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-026-20450-5","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:07:57Z","timestamp":1792271277000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Does Additional Margin Excision During Pegulicianine Fluorescence-Guided Surgery (pFGS) Affect Patient Breast Satisfaction?"],"prefix":"10.1245","author":[{"given":"Kyle J.","family":"Anderman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail E.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Tamirisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly K.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Shelley","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene L.","family":"Wapnir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Blumencranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan R.","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,17]]},"reference":[{"key":"20450_CR1","unstructured":"Helwick C. How accurate is the pathologic assessment of the partial mastectomy specimen? Retrieved 9 September 2025 at https:\/\/ascopost.com\/issues\/october-15-2014\/how-accurate-is-the-pathologic-assessment-of-the-partial-mastectomy-specimen\/."},{"key":"20450_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/s0002-9610(02)00902-9","volume":"184","author":"RA Graham","year":"2002","unstructured":"Graham RA, Homer MJ, Katz J, Rothschild J, Safaii H, Supran S. The pancake phenomenon contributes to the inaccuracy of margin assessment in patients with breast cancer. Am J Surg. 2002;184:89\u201393. https:\/\/doi.org\/10.1016\/s0002-9610(02)00902-9.","journal-title":"Am J Surg."},{"key":"20450_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.amjsurg.2014.09.029","volume":"210","author":"R Tang","year":"2015","unstructured":"Tang R, Coopey SB, Specht MC, Lei L, Gadd MA, Hughes KS, et al. Lumpectomy specimen margins are not reliable in predicting residual disease in breast conserving surgery. Am J Surg. 2015;210:93\u20138. https:\/\/doi.org\/10.1016\/j.amjsurg.2014.09.029.","journal-title":"Am J Surg."},{"key":"20450_CR4","doi-asserted-by":"publisher","first-page":"2200333","DOI":"10.1056\/EVIDoa2200333","volume":"2","author":"BL Smith","year":"2023","unstructured":"Smith BL, Hunt KK, Carr D, Blumencranz PW, et al. Intraoperative fluorescence guidance for breast cancer lumpectomy surgery. NEJM Evidence. 2023;2:2200333. https:\/\/doi.org\/10.1056\/EVIDoa2200333.","journal-title":"NEJM Evidence."},{"key":"20450_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1001\/jamasurg.2022.1075","volume":"157","author":"ES Hwang","year":"2022","unstructured":"Hwang ES, Beitsch P, Blumencranz P, et al. Clinical impact of intraoperative margin assessment in breast-conserving surgery with a novel pegulicianine fluorescence\u2013guided system: a nonrandomized controlled trial. JAMA Surg. 2022;157:573\u201380. https:\/\/doi.org\/10.1001\/jamasurg.2022.1075.","journal-title":"JAMA Surg."},{"key":"20450_CR6","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1200\/JCO.2013.53.3935","volume":"32","author":"MS Moran","year":"2014","unstructured":"Moran MS, Schnitt SJ, Giuliano AE, et al. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol. 2014;32:1507\u201315. https:\/\/doi.org\/10.1200\/JCO.2013.53.3935.","journal-title":"J Clin Oncol."},{"key":"20450_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.prro.2016.06.011","volume":"6","author":"M Morrow","year":"2016","unstructured":"Morrow M, Van Zee KJ, Solin LJ, et al. Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ. Pract Radiat Oncol. 2016;6:287\u201395. https:\/\/doi.org\/10.1016\/j.prro.2016.06.011.","journal-title":"Pract Radiat Oncol."},{"key":"20450_CR8","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.ijrobp.2017.11.047","volume":"100","author":"CW Swanick","year":"2018","unstructured":"Swanick CW, Lei X, Xu Y, et al. Long-term patient-reported outcomes in older breast cancer survivors: a population-based survey study. Int J Radiat Oncol Biol Phys. 2018;100:882\u201390. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.11.047.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"20450_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0b013e31823aec6b","author":"SJ Cano","year":"2012","unstructured":"Cano SJ, Klassen AF, Scott AM, et al. The BREAST-Q: further validation in independent clinical samples. Plast Recontr Surg. 2012;129(2):293-302. https:\/\/doi.org\/10.1097\/PRS.0b013e31823aec6b.","journal-title":"Plast Recontr Surg."},{"key":"20450_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0b013e3181aee807","author":"AL Pusic","year":"2009","unstructured":"Pusic AL, Klassen AF, Scott AM, et al. Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg. 2009;124(2):345-353. https:\/\/doi.org\/10.1097\/PRS.0b013e3181aee807.","journal-title":"Plast Reconstr Surg."},{"key":"20450_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s40271-013-0041-0","volume":"7","author":"TH Nguyen","year":"2014","unstructured":"Nguyen TH, Han HR, Kim MT, Chan KS. An introduction to item response theory for patient-reported outcome measurement. Patient. 2014;7:23\u201335. https:\/\/doi.org\/10.1007\/s40271-013-0041-0.","journal-title":"Patient."},{"key":"20450_CR12","doi-asserted-by":"publisher","first-page":"7597","DOI":"10.1245\/s10434-024-15795-811","volume":"31","author":"S Vemuru","year":"2024","unstructured":"Vemuru S, Helmkamp L, Adams M, et al. Longitudinal trends in patient-reported outcomes in the first year after lumpectomy versus mastectomy. Ann Surg Oncol. 2024;31:7597\u2013606. https:\/\/doi.org\/10.1245\/s10434-024-15795-811.","journal-title":"Ann Surg Oncol."},{"key":"20450_CR13","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1093\/jjco\/hyx099","volume":"47","author":"HY Tsai","year":"2017","unstructured":"Tsai HY, Kuo RN, Chung KP. Quality of life of breast cancer survivors following breast-conserving therapy versus mastectomy: a multicenter study in Taiwan. Japanese J Clin Oncol. 2017;47:909\u201318. https:\/\/doi.org\/10.1093\/jjco\/hyx099.","journal-title":"Japanese J Clin Oncol."},{"key":"20450_CR14","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10549-020-05964-0","volume":"185","author":"C Pesce","year":"2021","unstructured":"Pesce C, Jaffe J, Kuchta K, Yao K, Sisco M. Patient-reported outcomes among women with unilateral breast cancer undergoing breast conservation versus single or double mastectomy. Breast Cancer Res Treat. 2021;185:359\u201369. https:\/\/doi.org\/10.1007\/s10549-020-05964-0.","journal-title":"Breast Cancer Res Treat."},{"key":"20450_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1053\/ejso.1999.0708","volume":"25","author":"SK Al-Ghazal","year":"1999","unstructured":"Al-Ghazal SK, Fallowfield L, Blamey RW. Does cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity? Eur J Surg Oncol. 1999;25:571\u20133. https:\/\/doi.org\/10.1053\/ejso.1999.0708.","journal-title":"Eur J Surg Oncol."},{"key":"20450_CR16","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1200\/JCO.2007.13.1375","volume":"26","author":"JF Waljee","year":"2008","unstructured":"Waljee JF, Hu ES, Ubel PA, Smith DM, Newman LA, Alderman AK. Effect of esthetic outcome after breast-conserving surgery on psychosocial functioning and quality of life. J Clin Oncol. 2008;26:3331\u20137. https:\/\/doi.org\/10.1200\/JCO.2007.13.1375.","journal-title":"J Clin Oncol."},{"key":"20450_CR17","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.amjsurg.2022.03.008","volume":"224","author":"C Baliski","year":"2022","unstructured":"Baliski C, Bakos B. Patient reported outcomes following breast-conserving surgery are improved by minimizing re-excisions and excessive breast tissue removal. Am J Surg. 2022;224:716\u201321. https:\/\/doi.org\/10.1016\/j.amjsurg.2022.03.008.","journal-title":"Am J Surg."},{"key":"20450_CR18","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/bjs.4344","volume":"90","author":"RA Cochrane","year":"2003","unstructured":"Cochrane RA, Valasiadou P, Wilson AR, Al-Ghazal SK, Macmillan RD. Cosmesis and satisfaction after breast-conserving surgery correlates with the percentage of breast volume excised. Br J Surg. 2003;90:1505\u20139. https:\/\/doi.org\/10.1002\/bjs.4344.","journal-title":"Br J Surg."},{"key":"20450_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa1504473","volume":"373","author":"AB Chagpar","year":"2015","unstructured":"Chagpar AB, Killelea BK, Tsangaris TN, Butler M, Stavris K, Li F, et al. A randomized, controlled trial of cavity shave margins in breast cancer. N Engl J Med. 2015;373:503\u201310.","journal-title":"N Engl J Med."},{"key":"20450_CR20","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1097\/SLA.0000000000003449","volume":"273","author":"E Dupont","year":"2021","unstructured":"Dupont E, Tsangaris T, Garcia-Cantu C, et al. Resection of cavity shave margins in stage 0-III breast cancer patients undergoing breast-conserving surgery: a prospective multicenter randomized controlled trial. Ann Surg. 2021;273:876\u201381. https:\/\/doi.org\/10.1097\/SLA.0000000000003449. (PMID: 31290763).","journal-title":"Ann Surg."},{"key":"20450_CR21","doi-asserted-by":"publisher","first-page":"5341","DOI":"10.1245\/s10434-023-13592-3","volume":"30","author":"R Matar-Ujvary","year":"2023","unstructured":"Matar-Ujvary R, Haglich K, Flanagan MR, et al. The impact of breast-conserving surgery re-excision on patient-reported outcomes using the BREAST-Q. Ann Surg Oncol. 2023;30:5341\u20139. https:\/\/doi.org\/10.1245\/s10434-023-13592-3.","journal-title":"Ann Surg Oncol."},{"key":"20450_CR22","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1245\/s10434-011-1947-1","volume":"19","author":"J Heil","year":"2012","unstructured":"Heil J, Breitkreuz K, Golatta M, Czink E, Dahlkamp J, Rom J, et al. Do reexcisions impair aesthetic outcome in breast conservation surgery? Exploratory analysis of a prospective cohort study. Ann Surg Oncol. 2012;19:541\u20137. https:\/\/doi.org\/10.1245\/s10434-011-1947-1.","journal-title":"Ann Surg Oncol."},{"key":"20450_CR23","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jamcollsurg.2007.07.029","volume":"206","author":"JF Waljee","year":"2008","unstructured":"Waljee JF, Hu ES, Newman LA, Alderman AK. Predictors of breast asymmetry after breast-conserving operation for breast cancer. J Am Coll Surg. 2008;206:274\u201380. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2007.07.029.","journal-title":"J Am Coll Surg."},{"key":"20450_CR24","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1245\/s10434-019-07456-y","volume":"26","author":"I Stolpner","year":"2019","unstructured":"Stolpner I, Heil J, Fei\u00dft M, et al. Clinical validation of the BREAST-Q breast-conserving therapy module. Ann Surg Oncol. 2019;26:2759\u201367. https:\/\/doi.org\/10.1245\/s10434-019-07456-y.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20450-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20450-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20450-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:07:58Z","timestamp":1792271278000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20450-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,17]]},"references-count":24,"alternative-id":["20450"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20450-5","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,17]]},"assertion":[{"value":"6 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We are currently receiving research funding from Lumicell to collect follow-up and recurrence data for trial patients.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}